Enzymes III - Examples and Enzyme Inhibition
Chymotrypsin is a digestive enzyme produced by the pancreas. It plays a crucial role in the digestive system by hydrolyzing peptide bonds specifically at the carboxyl side of aromatic amino acids such as phenylalanine, tyrosine, and tryptophan, as well as leucine. This action is essential for the breakdown of proteins into smaller peptides, facilitating easier absorption in the intestine.
It is classified as a hydrolase, a subset of enzymes known as proteases that catalyze the hydrolytic cleavage of peptide bonds. This classification highlights its primary function in digestion. Chymotrypsinogen, the inactive precursor of chymotrypsin, is synthesized in the pancreas and activated in the small intestine by trypsin.
Characteristics of Chymotrypsin
Structure:
Composed of three polypeptide chains linked by disulfide bonds, giving it a stable three-dimensional structure crucial for its function:
A chain
B chain
C chain
Active Site:
The enzyme's active site is characterized by a hydrophobic pocket and a catalytic triad composed of three key amino acids:
Histidine (His57)
Aspartate (Asp102)
Serine (Ser195)
Mechanism of Action
Chymotrypsin operates through a sophisticated two-phase mechanism:
Acylation Phase:
The peptide bond is cleaved, resulting in the formation of an ester linkage between the substrate's carbonyl carbon and Ser195 from the enzyme.
Deacylation Phase:
In this phase, the ester linkage is hydrolyzed, leading to the regeneration of the nonacylated enzyme.
Overall Reaction:
Detailed Steps of Mechanism:
The substrate binds to the hydrophobic pocket.
The -OH group of Ser195 transfers an H+ to His57, which then executes a nucleophilic attack on the carbonyl carbon of the peptide bond.
The peptide bond is cleaved, forming a covalent acyl bond between Ser195 and the substrate.
A water molecule enters the active site, interacting with His57 to form a hydrogen bond.
His57 abstracts an H+ from the water molecule, facilitating an attack on the carbonyl carbon that allows for the release of the second peptide fragment.
Chymotrypsin is regenerated to its original form, ready for another catalytic cycle.
Enzyme Activity and Regulation
Chymotrypsin demonstrates a clear dependence on pH for its activity, showing optimal performance at pH 8. At this pH, His57 is unprotonated, which is vital for the enzyme's catalytic action.
Hexokinase plays a pivotal role in glycolysis by catalyzing the phosphorylation of glucose to form glucose-6-phosphate, a key step in the metabolic pathway that converts glucose to energy.
Cofactor:
Hexokinase requires Mg2+ ions for its enzymatic activity, as they are essential for stabilizing the ATP molecule, which is the phosphate donor in the reaction.
Kinetic Parameters:
The substrates for Hexokinase are glucose and ATP. The affinity of Hexokinase for its substrates is characterized by the Michaelis constant (Km), with the following values for various substrates:
Hexokinase (brain):
ATP:
D-Glucose:
D-Fructose:
Binding Mechanism:
The enzyme operates through an induced fit mechanism, wherein substrate binding induces a conformational change in the enzyme, allowing it to reach a catalytic active state.
Enzyme Inhibition
General Overview
Enzyme inhibitors are crucial in regulating enzymatic reactions and are often utilized in pharmaceutical applications to modulate biological pathways. Examples of inhibitors include:
Ibuprofen (anti-inflammatory)
Penicillin (antibiotic)
Lovastatin (cardiovascular disease)
Indinavir (used in the treatment of AIDS)
Types of Enzyme Inhibitors
Reversible Inhibitors:
Bind loosely to the enzyme and can dissociate rapidly, allowing for regulatory control over enzyme activity.
Irreversible Inhibitors:
Form covalent bonds or stable complexes with the enzyme, leading to permanent inhibition of enzymatic activity.
Reversible Inhibitors
Mechanisms:
Competitive Inhibitors:
Resemble the substrate and bind to the active site, competing for access; their effects can be mitigated by increasing substrate concentration.
Example: Ibuprofen inhibits cyclooxygenase, reducing pain and inflammation.
Uncompetitive Inhibitors:
Bind only to the enzyme-substrate complex, preventing the reaction from proceeding; their presence reduces both Vmax and Km.
Example: Glyphosate in herbicides can deactivate specific enzymes in prolonged exposure.
Mixed Inhibitors:
Have the ability to bind both the enzyme and the enzyme-substrate complex, thus lowering Vmax without altering Km.
Example: Etoposide is used in cancer treatment by impairing topoisomerase function.
Irreversible Inhibitors
These inhibitors bind tightly, often through covalent interactions, leading to permanent loss of enzyme activity.
Types:
Group-Specific Reagents: Bind to specific amino acids within the enzyme (e.g., DIPF).
Reactive Substrate Analogs: Mimic the substrate to inhibit the enzyme (e.g., TPCK for chymotrypsin).
Mechanism-Based Inhibitors: The enzyme acts on the inhibitor, leading to self-inactivation (e.g., Penicillin).
Penicillin's Mechanism:
Penicillin functions as an irreversible inhibitor of the enzyme transpeptidase, critical for bacterial cell wall synthesis. It binds to the active site and forms a stable, inactive complex, effectively halting the ability of bacteria to maintain their cell structure and ultimately leading to cell lysis.
In conclusion, both chymotrypsin and hexokinase exemplify how enzymes function in metabolic pathways and how their activity can be modulated by various factors, reflecting the complexity of biochemical regulation.